Company
Business
Stem Cell Therapy
Organoid
CDMO Business
Kangstem Biotech is advancing innovative therapies through its cell therapy and organoid platforms, with a strong foundation in scientific evidence and clinical potential.
|
2015.01
Journal : Scientific Reports
|
|
2014.11
Journal : BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
|
|
2014.10
Journal : PLoS One
|
|
2013.12
Journal : GASTROENTEROLOGY
|
|
2013.12
Journal : JOURNAL OF CELL SCIENCE
|
Stem Cell Therapy
Organoid
CDMO Business